UnknownNot Applicable

Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

55 participantsStarted 2023-11-01

Plain-language summary

assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry

Who can participate

Age range16 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients \>16years old with sepsis associated with disturbance in conscious level admitted to ICU Exclusion Criteria: * Age\< 16y Brain death Hematological disease Malignant disease Hypoxemia Error in automatic tissue classification Motion artifac

What they're measuring

- Correlation between sepsis and brain volume reduction . - Determine the role of the CT scan in assess brain volume in acute phase of sepsis and it,s influences in improvement activities of daily living.

Timeframe: follow up through 10 days after admission in ICU

Trial details

NCT IDNCT06112119

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-11-01

Contact for this trial

Nada mohamed abdelmoneim

01097151396 abdelmoneimnada44@gmail.com

View on ClinicalTrials.gov More Sepsis-Associated Encephalopathy trials